Robust cross-cohort gut microbiome associations with COVID-19 severity

References

• Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–24. doi:10.1016/S1473-3099(20)30120-1.
   PubMed Web of Science ®Google Scholar
• Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, Lavin Y, Swartz TH, Madduri D, Stock A, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26(10):1636–1643. doi:10.1038/s41591-020-1051-9.
   PubMed Web of Science ®Google Scholar
• Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355–362. doi:10.1038/s41577-020-0331-4.
   PubMed Web of Science ®Google Scholar
• Junqueira C, Crespo Â, Ranjbar S, de Lacerda LB, Lewandrowski M, Ingber J, Parry B, Ravid S, Clark S, Schrimpf MR, et al. FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature. 2022;606(7914):576–584. doi:10.1038/s41586-022-04702-4.
   PubMed Web of Science ®Google Scholar
• Hodges G, Pallisgaard J, Schjerning Olsen AM, McGettigan P, Andersen M, Krogager M, Kragholm K, Køber L, Gislason GH, Torp-Pedersen C, et al. Association between biomarkers and COVID-19 severity and mortality: a nationwide danish cohort study. BMJ Open. 2020;10(12):e041295. doi:10.1136/bmjopen-2020-041295.
   PubMed Web of Science ®Google Scholar
• Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, Chen X, Chen S, Yu K, Huang Z, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care. 2020;8(1):49. doi:10.1186/s40560-020-00466-z.
   PubMed Web of Science ®Google Scholar
• Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, Deng G. Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Int J Infect Dis. 2020;96:467–474. doi:10.1016/j.ijid.2020.05.055.
   PubMed Web of Science ®Google Scholar
• Mahat RK, Panda S, Rathore V, Swain S, Yadav L, Sah SP. The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: a systematic review and meta-analysis. Clin Epidemiol Global Health. 2021;11:11. doi:10.1016/j.cegh.2021.100727.
   Web of Science ®Google Scholar
• Ahearn-Ford S, Lunjani N, McSharry B, MacSharry J, Fanning L, Murphy G, Everard C, Barry A, McGreal A, Lawati SM, et al. Long-term disruption of cytokine signalling networks is evident in patients who required hospitalization for SARS-CoV-2 infection. Allergy. 2021;76(9):2910–2913. doi:10.1111/all.14953.
   PubMed Web of Science ®Google Scholar
• D’Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management. Clin Gastroenterol Hepatol. 2020;18(8):1663–1672. doi:10.1016/j.cgh.2020.04.001.
   PubMed Web of Science ®Google Scholar
• Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, Li P, Hu B, Wang J, Hu C, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115(5):766–773. doi:10.14309/ajg.0000000000000620.
   PubMed Web of Science ®Google Scholar
• Blackett JW, Wainberg M, Elkind MSV, Freedberg DE. Potential long coronavirus disease 2019 gastrointestinal symptoms 6 months after coronavirus infection are associated with mental health symptoms. Gastroenterol. 2022;162(2):648–50.e2. doi:10.1053/j.gastro.2021.10.040.
   PubMed Web of Science ®Google Scholar
• Cooney J, Appiahene P, Findlay R, Al-Hillawi L, Rafique K, Laband W, Shandro B, Poullis A. COVID-19 infection causing residual gastrointestinal symptoms – a single UK centre case series. Clin Med (Northfield Il). 2022;22(2):181. doi:10.7861/clinmed.2021-0522.
   PubMed Web of Science ®Google Scholar
• Zeng W, Qi K, Ye M, Zheng L, Liu X, Hu S, Zhang W, Tang W, Xu J, Yu D, et al. Gastrointestinal symptoms are associated with severity of coronavirus disease 2019: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2022;34(2):168–176. doi:10.1097/MEG.0000000000002072.
   PubMed Web of Science ®Google Scholar
• Wang B, Zhang L, Wang Y, Dai T, Qin Z, Zhou F, Zhang L. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Sig Transduct Target Ther. 2022;7(1):143. doi:10.1038/s41392-022-00986-0.
   PubMed Web of Science ®Google Scholar
• Chen R, Yu YL, Li W, Liu Y, Lu JX, Chen F, Zhou Q, Xia ZY, Gao L, Meng QT, et al. Gastrointestinal symptoms associated with unfavorable prognosis of COVID-19 patients: a retrospective study. Front Med. 2020;7. doi:10.3389/fmed.2020.608259.
   Web of Science ®Google Scholar
• Wang Y, Li Y, Zhang Y, Liu Y, Liu Y. Are gastrointestinal symptoms associated with higher risk of mortality in COVID-19 patients? A systematic review and meta-analysis. BMC Gastroenterol. 2022;22(1):106. doi:10.1186/s12876-022-02132-0.
   PubMed Web of Science ®Google Scholar
• Geva-Zatorsky N, Sefik E, Kua L, Pasman L, Tan TG, Ortiz-Lopez A, Yanortsang TB, Yang L, Jupp R, Mathis D, et al. Mining the human gut microbiota for immunomodulatory organisms. Cell. 2017;168(5):928–43.e11. doi:10.1016/j.cell.2017.01.022.
   PubMed Web of Science ®Google Scholar
• Forde B, Yao L, Shaha R, Murphy S, Lunjani N, O’Mahony L. Immunomodulation by foods and microbes: unravelling the molecular tango. Allergy. 2022;77(12):3513–3526. n/a. doi:10.1111/all.15455.
   PubMed Web of Science ®Google Scholar
• Liu Q, Mak JWY, Su Q, Yeoh YK, Lui G-Y, Ng SSS, Zhang F, Li AYL, Lu W, Hui DSC, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71(3):544–552. doi:10.1136/gutjnl-2021-325989.
   PubMed Web of Science ®Google Scholar
• Yeoh YK, Zuo T, Lui GCY, Zhang F, Liu Q, Li AY, Chung AC, Cheung CP, Tso EY, Fung KS, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698. doi:10.1136/gutjnl-2020-323020.
   PubMed Web of Science ®Google Scholar
• Albrich WC, Ghosh TS, Ahearn-Ford S, Mikaeloff F, Lunjani N, Forde B, Suh N, Kleger GR, Pietsch U, Frischknecht M, et al. A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2. Gut Microbes. 2022;14(1):2073131. doi:10.1080/19490976.2022.2073131.
   PubMed Web of Science ®Google Scholar
• Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung ACK, Cheung CP, Chen N, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterol. 2020;159(3):944–55.e8. doi:10.1053/j.gastro.2020.05.048.
   PubMed Web of Science ®Google Scholar
• Schult D, Reitmeier S, Koyumdzhieva P, Lahmer T, Middelhof M, Erber J, Schneider J, Kager J, Frolova M, Horstmann J, et al. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19. Gut Microbes. 2022;14(1):2031840. doi:10.1080/19490976.2022.2031840.
   PubMed Web of Science ®Google Scholar
• Su Q, Lau RI, Liu Q, Chan FKL, Ng SC. Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance. Gut. 2022;72(6):1230–1232. doi:10.1136/gutjnl-2022-328319.
   PubMed Web of Science ®Google Scholar
• Sun Z, Song ZG, Liu C, Tan S, Lin S, Zhu J, Dai FH, Gao J, She JL, Mei Z, et al. Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients. BMC Med. 2022;20(1):24. doi:10.1186/s12916-021-02212-0.
   PubMed Web of Science ®Google Scholar
• Giannos P, Prokopidis K. Gut dysbiosis and long COVID-19: feeling gutted. J Med Virol. 2022;94(7):2917–2918. doi:10.1002/jmv.27684.
   PubMed Web of Science ®Google Scholar
• Sadlier C, Albrich WC, Neogi U, Lunjani N, Horgan M, O’Toole PW, O’Mahony L. Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19. Allergy. 2022;77(5):1623–1625. doi:10.1111/all.15253.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu G, Zhao L, Wang W, Cooper Vaughn S, Cooper VS. Nutritional modulation of gut microbiota alleviates severe gastrointestinal symptoms in a patient with post-acute COVID-19 syndrome. mBio. 2022;13(2):e03801–21. doi:10.1128/mbio.03801-21.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a delphi consensus. Lancet Infect Dis. 2022;22(4):e102–e107. doi:10.1016/S1473-3099(21)00703-9.
   PubMed Web of Science ®Google Scholar
• Ancona G, Alagna L, Alteri C, Palomba E, Tonizzo A, Pastena A, Muscatello A, Gori A, Bandera A. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID. Front Immunol. 2023;14:14. doi:10.3389/fimmu.2023.1080043.
   Web of Science ®Google Scholar
• Gareau MG, Barrett KE. Role of the microbiota-gut-brain axis in postacute COVID syndrome. Am J Physiol-Gastr L. 2023;324(4):G322–G328. doi:10.1152/ajpgi.00293.2022.
   PubMed Web of Science ®Google Scholar
• Beghini F, McIver LJ, Blanco-Míguez A, Dubois L, Asnicar F, Maharjan S, Mailyan A, Manghi P, Scholz M, Thomas AM, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife. 2021;10:e65088. doi:10.7554/eLife.65088.
   PubMed Web of Science ®Google Scholar
• Allard G, Ryan FJ, Jeffery IB, Claesson MJ. SPINGO: a rapid species-classifier for microbial amplicon sequences. BMC Bioinform. 2015;16(1):324. doi:10.1186/s12859-015-0747-1.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44(D1):D457–D462. doi:10.1093/nar/gkv1070.
   PubMed Web of Science ®Google Scholar
• Caspi R, Billington R, Ferrer L, Foerster H, Fulcher CA, Keseler IM, Kothari A, Krummenacker M, Latendresse M, Mueller LA, et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res. 2016;44(D1):D471–D480. doi:10.1093/nar/gkv1164.
   PubMed Web of Science ®Google Scholar
• Drula E, Garron ML, Dogan S, Lombard V, Henrissat B, Terrapon N. The carbohydrate-active enzyme database: functions and literature. Nucleic Acids Res. 2022;50(D1):D571–D577. doi:10.1093/nar/gkab1045.
   PubMed Web of Science ®Google Scholar
• Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, Avila-Pacheco J, Poon TW, Andrews E, Ajami NJ, Bonham KS, Brislawn CJ, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569(7758):655–662. doi:10.1038/s41586-019-1237-9.
   PubMed Web of Science ®Google Scholar
• Ferreira-Junior AS, Borgonovi TF, de Salis LV, Leite AZ, Dantas AS, de Salis GV, Cruz GN, de Oliveira LF, Gomes E, Penna AL, et al. Detection of intestinal dysbiosis in post-COVID-19 patients one to eight months after acute disease resolution. Int J Environ Res Public Health.2022;19(16):10189. doi:10.3390/ijerph191610189.
   PubMed Web of Science ®Google Scholar
• Chen Y, Gu S, Chen Y, Lu H, Shi D, Guo J, Wu WR, Yang Y, Li Y, Xu KJ, et al. Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut. 2022;71(1):222. doi:10.1136/gutjnl-2021-324090.
   PubMed Web of Science ®Google Scholar
• Bai Z, Li Q, Chen Q, Niu C, Wei Y, Huang H, Zhao W, Chen N, Yao X, Zhang Q, et al. Clinical significance of serum IgM and IgG levels in COVID-19 patients in Hubei Province, China. J Intensive Med. 2022;2(1):32–38. doi:10.1016/j.jointm.2021.09.001.
   PubMedGoogle Scholar
• Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. Isme J. 2017;11(4):841–852. doi:10.1038/ismej.2016.176.
   PubMed Web of Science ®Google Scholar
• Engevik MA, Luk BK, Visuthranukul C, Versalovic J. Bifidobacterium dentium regulates intestinal mucus production and glycosylation. Faseb J. 2017;31:.954.5–.5.
   Web of Science ®Google Scholar
• Taras D, Simmering R, Collins MD, Lawson PA, Blaut M. Reclassification of eubacterium formicigenerans Holdeman and Moore 1974 as dorea formicigenerans gen. nov., comb. nov., and description of dorea longicatena sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2002;52(2):423–428. doi:10.1099/00207713-52-2-423.
   PubMedGoogle Scholar
• Daniel Steven L, Moradi L, Paiste H, Wood Kyle D, Assimos Dean G, Holmes Ross P, Nazzal L, Hatch M, Knight J. Forty years of oxalobacter formigenes, a gutsy oxalate-degrading specialist. Appl Environ Microb. 2021;87(18):e00544–21. doi:10.1128/AEM.00544-21.
   PubMed Web of Science ®Google Scholar
• Weber E, Reynaud Q, Suy F, Gagneux-Brunon A, Carricajo A, Guillot A, Botelho-Nevers E. Bifidobacterium species bacteremia: risk factors in adults and infants: table 1. Clin Infect Dis. 2015;61(3):482–484. doi:10.1093/cid/civ347.
   PubMed Web of Science ®Google Scholar
• DeVoe C, Segal MR, Wang L, Stanley K, Madera S, Fan J, Schouest J, Graham-Ojo R, Nichols A, Prasad PA, et al. Increased rates of secondary bacterial infections, including enterococcus bacteremia, in patients hospitalized with coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol. 2021;43(10):1416–1423. doi:10.1017/ice.2021.391.
   PubMed Web of Science ®Google Scholar
• Edbert D, Mertaniasih N, Endraswari P. Phenotypic analyses of blood culture contaminants in COVID-19 intensive care unit using hierarchical clustering during the pandemic first wave in surabaya. Pathol Laborat Med Int. 2022;14:7–13. doi:10.2147/PLMI.S356299.
   Web of Science ®Google Scholar
• Protonotariou E, Mantzana P, Meletis G, Tychala A, Kassomenaki A, Vasilaki O, Kagkalou G, Gkeka I, Archonti M, Kati S, et al. Microbiological characteristics of bacteremias among COVID-19 hospitalized patients in a tertiary referral hospital in Northern Greece during the second epidemic wave. FEMS Microbes. 2021;2:xtab021. doi:10.1093/femsmc/xtab021.
   PubMedGoogle Scholar
• Lunjani N, Albrich WC, Suh N, Barda B, Finnegan LA, Dam SA, Walter J, Sadlier C, Horgan M, O’Toole PW, et al. Higher levels of bacterial DNA in serum associate with severe and fatal COVID-19. Allergy. 2022;77(4):1312–1314. doi:10.1111/all.15218.
   PubMed Web of Science ®Google Scholar
• Pasolli E, Schiffer L, Manghi P, Renson A, Obenchain V, Truong DT, Beghini F, Malik F, Ramos M, Dowd JB, et al. Accessible, curated metagenomic data through ExperimentHub. Nat Methods. 2017;14(11):1023–1024. doi:10.1038/nmeth.4468.
   PubMed Web of Science ®Google Scholar
• Do T, Henssge U, Gilbert SC, Clark D, Beighton D. Evidence for recombination between a sialidase (nanH) of actinomyces naeslundii and actinomyces oris, previously named ‘Actinomyces naeslundii genospecies 1 and 2’ FEMS Microbiol Lett. 2008;288(2):156–162. doi:10.1111/j.1574-6968.2008.01336.x.
   PubMed Web of Science ®Google Scholar
• Ton-That H, Das A, Mishra A. Actinomyces oris Fimbriae: an Adhesive Principle in Bacterial Biofilms and Tissue Tropism. In: Kolenbrander PE, ed. Oral Microbial Communities: Genomic Inquiry and Interspecies Communication. Washington, DC: ASM Press; 2011. Actinomyces oris Fimbriae: an Adhesive Principle in Bacterial Biofilms and Tissue Tropism; 63–77. doi:10.1128/9781555817107.ch5.
   Google Scholar
• Settanni CR, Ianiro G, Ponziani FR, Bibbò S, Segal JP, Cammarota G, Gasbarrini A. COVID-19 as a trigger of irritable bowel syndrome: a review of potential mechanisms. World J Gastroenterol. 2021;27(43):7433–7445. doi:10.3748/wjg.v27.i43.7433.
   PubMed Web of Science ®Google Scholar
• Vélez C, Paz M, Silvernale C, Stratton LW, Kuo B, Staller K, Barreto E, Vergara Cobos J, Buchanan KL, Boyd T, et al. Factors associated with chronic De novo post-coronavirus disease gastrointestinal disorders in a metropolitan US County. Clin Gastroenterol Hepatol. 2022;20(6):e1488–e1492. doi:10.1016/j.cgh.2021.10.020.
   PubMed Web of Science ®Google Scholar
• Austhof E, Bell ML, Riddle MS, Catalfamo C, McFadden C, Cooper K, Walter ES, Jacobs E, Pogreba-Brown K. Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the arizona CoVHORT. Epidemiol Infect. 2022;150:e136. doi:10.1017/S0950268822001200.
   PubMed Web of Science ®Google Scholar
• Ghoshal UC, Ghoshal U, Rahman MM, Mathur A, Rai S, Akhter M, Mostafa T, Islam MS, Haque SA, Pandey A, et al. Post-infection functional gastrointestinal disorders following coronavirus disease-19: A case–control study. J Gastroen Hepatol. 2022;37(3):489–498. doi:10.1111/jgh.15717.
   PubMed Web of Science ®Google Scholar
• Noviello D, Costantino A, Muscatello A, Bandera A, Consonni D, Vecchi M, Basilisco G. Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: a controlled cohort study. Neurogastroent Motil. 2022;34(2):e14187. doi:10.1111/nmo.14187.
   PubMed Web of Science ®Google Scholar
• Marasco G, Cremon C, Barbaro MR, Cacciari G, Falangone F, Kagramanova A, Bordin D, Drug V, Miftode E, Fusaroli P, et al. Post COVID-19 irritable bowel syndrome. Gut. 2022:gutjnl-2022–328483. doi:10.1136/gutjnl-2022-328483.
   Google Scholar
• Ghoshal UC, Gwee KA. Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link. Nat Rev Gastro Hepat. 2017;14(7):435–441. doi:10.1038/nrgastro.2017.37.
   PubMed Web of Science ®Google Scholar
• Jeffery IB, Das A, O’Herlihy E, Coughlan S, Cisek K, Moore M, Bradley F, Carty T, Pradhan M, Dwibedi C, et al. Differences in fecal microbiomes and metabolomes of people with vs without irritable bowel syndrome and bile acid malabsorption. Gastroenterol. 2020;158(4):1016–28.e8. doi:10.1053/j.gastro.2019.11.301.
   PubMed Web of Science ®Google Scholar
• Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, Kurilshikov A, Bonder MJ, Jiang X, Tigchelaar EF, et al. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med. 2018;10(472):eaap8914. doi:10.1126/scitranslmed.aap8914.
   PubMed Web of Science ®Google Scholar
• Cusack S, O’Connor EM, O’Toole PW. ELDERMET (Ireland). In: Nelson K, editor. Encyclopedia of metagenomics. New York, NY:Springer New York; 2013. p. 1–11. doi:10.1007/978-1-4614-6418-1_94-1.
   Google Scholar
• Barton W, Penney NC, Cronin O, Garcia-Perez I, Molloy MG, Holmes E, Shanahan F, Cotter PD, O’Sullivan O. The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut. 2018;67:625. doi:10.1136/gutjnl-2016-313627.
   PubMed Web of Science ®Google Scholar
• Reinold J, Farahpour F, Schoerding AK, Fehring C, Dolff S, Konik M, Korth J, van Baal L, Buer J, Witzke O, et al. The fungal gut microbiome exhibits reduced diversity and increased relative abundance of ascomycota in severe COVID-19 illness and distinct interconnected communities in SARS-CoV-2 positive patients. Front Cell Infect Microbiol. 2022;12:12. doi:10.3389/fcimb.2022.848650.
   Web of Science ®Google Scholar
• Lv L, Gu S, Jiang H, Yan R, Chen Y, Chen Y, Luo R, Huang C, Lu H, Zheng B, et al. Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features. Commun Biol. 2021;4(1):480. doi:10.1038/s42003-021-02036-x.
   PubMed Web of Science ®Google Scholar
• Cao J, Wang C, Zhang Y, Lei G, Xu K, Zhao N, Lu J, Meng F, Yu L, Yan J, et al. Integrated gut virome and bacteriome dynamics in COVID-19 patients. Gut Microbes. 2021;13(1):1887722. doi:10.1080/19490976.2021.1887722.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Seidel D, Sprute R, Cunha C, Oliverio M, Goldman GH, Ibrahim AS, Carvalho A. COVID-19-associated fungal infections. Nature Microbiol. 2022;7(8):1127–1140. doi:10.1038/s41564-022-01172-2.
   PubMed Web of Science ®Google Scholar
• Liu Q, Su Q, Zhang F, Tun HM, Mak JWY, Lui GCY, Ng SSS, Ching JYL, Li A, Lu W, et al. Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome. Nat Commun. 2022;13(1):6806. doi:10.1038/s41467-022-34535-8.
   PubMed Web of Science ®Google Scholar
• Britton GJ, Chen-Liaw A, Cossarini F, Livanos AE, Spindler MP, Plitt T, Eggers J, Mogno I, Gonzalez-Reiche AS, Siu S, et al. Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. Sci Rep. 2021;11(1):13308. doi:10.1038/s41598-021-92740-9.
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7.
   PubMed Web of Science ®Google Scholar
• Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2021;2(1):e13–e22. doi:10.1016/S2666-5247(20)30172-5.
   PubMedGoogle Scholar
• Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, Park RM, Han A, Schmidtke DT, Verma R, et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 2022;3(6):371–87.e9. doi:10.1016/j.medj.2022.04.001.
   PubMedGoogle Scholar
• Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, Yin H, Xiao Q, Tang Y, Qu X, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020;5(5):434–435. doi:10.1016/S2468-1253(20)30083-2.
   PubMed Web of Science ®Google Scholar
• Prasad R, Patton MJ, Floyd JL, Fortmann S, DuPont M, Harbour A, Wright J, Lamendella R, Stevens BR, Oudit GY, et al. Plasma microbiome in COVID-19 subjects: an indicator of gut barrier defects and dysbiosis. Int J Mol Sci. 2022;23(16):23. doi:10.3390/ijms23169141.
   Web of Science ®Google Scholar
• Bernard-Raichon L, Venzon M, Klein J, Axelrad JE, Zhang C, Sullivan AP, Hussey GA, Casanovas-Massana A, Noval MG, Valero-Jimenez AM, et al. Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nat Commun. 2022;13(1):5926. doi:10.1038/s41467-022-33395-6.
   PubMed Web of Science ®Google Scholar
• Posteraro B, Torelli R, Vella A, Leone PM, De Angelis G, De Carolis E, Ventura G, Sanguinetti M, Fantoni M. Pan-echinocandin-resistant Candida glabrata bloodstream infection complicating COVID-19: a fatal case report. J Fungi. 2020;6(3):163. doi:10.3390/jof6030163.
   Web of Science ®Google Scholar
• Blaize M, Raoelina A, Kornblum D, Kamus L, Lampros A, Berger M, Demeret S, Constantin JM, Monsel A, Mayaux J, et al. Occurrence of candidemia in patients with COVID-19 admitted to five ICUs in France. J Fungi (Basel). 2022;8(7):678. doi:10.3390/jof8070678.
   PubMedGoogle Scholar
• Li J, Mau RL, Dijkstra P, Koch BJ, Schwartz E, Liu XJ, Morrissey EM, Blazewicz SJ, Pett-Ridge J, Stone BW, et al. Predictive genomic traits for bacterial growth in culture versus actual growth in soil. Isme J. 2019;13(9):2162–2172. doi:10.1038/s41396-019-0422-z.
   PubMed Web of Science ®Google Scholar
• Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, Fleck JS, Voigt AY, Palleja A, Ponnudurai R, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25(4):679–689. doi:10.1038/s41591-019-0406-6.
   PubMed Web of Science ®Google Scholar
• Ghosh TS, Shanahan F, O’Toole PW. Toward an improved definition of a healthy microbiome for healthy aging. Nat Aging. 2022;2(11):1054–1069. doi:10.1038/s43587-022-00306-9.
   PubMedGoogle Scholar
• Escobar-Zepeda A, Godoy-Lozano EE, Raggi L, Segovia L, Merino E, Gutiérrez-Rios RM, Juarez K, Licea-Navarro AF, Pardo-Lopez L, Sanchez-Flores A, et al. Analysis of sequencing strategies and tools for taxonomic annotation: defining standards for progressive metagenomics. Sci Rep. 2018;8(1):12034. doi:10.1038/s41598-018-30515-5.
   PubMedGoogle Scholar
• Hung YM, Lyu WN, Tsai ML, Liu CL, Lai LC, Tsai MH, Chuang EY. To compare the performance of prokaryotic taxonomy classifiers using curated 16S full-length rRNA sequences. Comput Biol Med. 2022;145:105416. doi:10.1016/j.compbiomed.2022.105416.
   PubMed Web of Science ®Google Scholar
• Hillmann B, Al-Ghalith Gabriel A, Shields-Cutler Robin R, Zhu Q, Gohl Daryl M, Beckman Kenneth B, Knight R, Knights D. Evaluating the information content of shallow shotgun metagenomics. mSystems. 2018;3(6):e00069–18. doi:10.1128/mSystems.00069-18.
   PubMed Web of Science ®Google Scholar
• Wang J, Guo R, Ma W, Dong X, Yan S, Xie W. Eggerthella lenta bacteremia in a middle-aged healthy man with acute hepatic abscess: case report and literature review, 1970–2020. Infect Drug Resist. 2021;14:3307–3318. doi:10.2147/IDR.S321282.
   PubMed Web of Science ®Google Scholar
• Dong X, Guthrie BGH, Alexander M, Noecker C, Ramirez L, Glasser NR, Turnbaugh PJ, Balskus EP. Genetic manipulation of the human gut bacterium Eggerthella lenta reveals a widespread family of transcriptional regulators. Nat Commun. 2022;13(1):7624. doi:10.1038/s41467-022-33576-3.
   PubMed Web of Science ®Google Scholar
• Ugarte-Torres A, Gillrie MR, Griener TP, Church DL. Eggerthella lenta bloodstream infections are associated with increased mortality following empiric piperacillin-tazobactam (TZP) monotherapy: a population-based cohort study. Clin Infect Dis. 2018;67(2):221–228. doi:10.1093/cid/ciy057.
   PubMed Web of Science ®Google Scholar
• Jiang S, E EJ, Wang D, Zou Y, Liu X, Xiao H, Wen Y, Chen Z. Eggerthella lenta bacteremia successfully treated with ceftizoxime: case report and review of the literature. Eur J Med Res. 2021;26(1):111. doi:10.1186/s40001-021-00582-y.
   PubMed Web of Science ®Google Scholar
• Nagaoka R, Kitagawa H, Koba Y, Tadera K, Hara T, Kashiyama S, Nomura T, Omori K, Shigemoto N, Yokozaki M, et al. Clinical and microbiological characteristics of eggerthella lenta bacteremia at a Japanese tertiary hospital. J Infect Chemotherap. 2021;27(8):1261–1264. doi:10.1016/j.jiac.2021.03.019.
   PubMed Web of Science ®Google Scholar
• Davis K, Peng C. A case of eggerthella bacteremia in a patient with COVID-19. Chest. 2022;162(4):A855. doi:10.1016/j.chest.2022.08.677.
   Web of Science ®Google Scholar
• Issa E, Salloum T, Tokajian S. From normal flora to brain abscesses: a review of streptococcus intermedius. Front Microbiol. 2020;11:11. doi:10.3389/fmicb.2020.00826.
   Web of Science ®Google Scholar
• Pilarczyk-Zurek M, Sitkiewicz I, Koziel J. The clinical view on streptococcus anginosus group - opportunistic pathogens coming out of hiding. Front Microbiol. 2022;13:956677. doi:10.3389/fmicb.2022.956677.
   PubMed Web of Science ®Google Scholar
• Al Majid F, Aldrees A, Barry M, Binkhamis K, Allam A, Almohaya A. Streptococcus anginosus group infections: management and outcome at a tertiary care hospital. J Infect Public Health. 2020;13(11):1749–1754. doi:10.1016/j.jiph.2020.07.017.
   PubMed Web of Science ®Google Scholar
• Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, Fernandez-Pittol M, Pitart C, Inciarte A, Bodro M, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83–88. doi:10.1016/j.cmi.2020.07.041.
   PubMed Web of Science ®Google Scholar
• Wong LY, Sukumar M, Fuss C, Thanawala R. Pulmonary vascular complication associated with coronavirus infection and role of lung resection. Ann Thorac Surg. 2022;115(4):e89–e91. doi:10.1016/j.athoracsur.2022.04.016.
   PubMed Web of Science ®Google Scholar
• Martini AM, Moricz BS, Ripperger AK, Tran PM, Sharp ME, Forsythe AN, Kulhankova K, Salgado-Pabón W, Jones BD. Association of novel streptococcus sanguinis virulence factors with pathogenesis in a native valve infective endocarditis model. Front Microbiol. 2020;11:11. doi:10.3389/fmicb.2020.00010.
   Web of Science ®Google Scholar
• Arbune M, Iancu AV, Lupasteanu G, Vasile MC, Stefanescu V. A challenge of COVID—19: associated infective endocarditis with streptococcus gordonii in a young immunocompetent patient. Medicina. 2021;57(12):1298. doi:10.3390/medicina57121298.
   PubMedGoogle Scholar
• Biliński J, Winter K, Jasiński M, Szczęś A, Bilinska N, Mullish BH, Małecka-Panas E, Basak GW. Rapid resolution of COVID-19 after faecal microbiota transplantation. Gut. 2022;71(1):230. doi:10.1136/gutjnl-2021-325010.
   PubMed Web of Science ®Google Scholar
• Liu F, Ye S, Zhu X, He X, Wang S, Li Y, Lin J, Wang J, Lin Y, Ren X, et al. Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients. J Med Case Rep. 2021;15(1):60. doi:10.1186/s13256-020-02583-7.
   PubMedGoogle Scholar
• de Almeida VM, Engel DF, Ricci MF, Cruz CS, Lopes IS, Alves DA, Auriol MD, Magalhães J, Zuccoli GS, Smith BJ, et al. Gut microbiota from patients with mild COVID-19 cause alterations in mice that resemble post-COVID syndrome. 2022. doi:10.21203/rs.3.rs-1756189.
   Google Scholar
• Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, Mujagic Z, Vila AV, Falony G, Vieira-Silva S, et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 2016;352(6285):565–569. doi:10.1126/science.aad3369.
   PubMed Web of Science ®Google Scholar
• Le Roy CI, Wells PM, Si J, Raes J, Bell JT, Spector TD. Red wine consumption associated with increased gut microbiota α-diversity in 3 independent cohorts. Gastroenterol. 2020;158(1):270–2.e2. doi:10.1053/j.gastro.2019.08.024.
   PubMed Web of Science ®Google Scholar
• Peters V, Tigchelaar-Feenstra EF, Imhann F, Dekens JAM, Swertz MA, Franke LH, Wijmenga C, Weersma RK, Alizadeh BZ, Dijkstra G, et al. Habitual dietary intake of IBD patients differs from population controls: a case–control study. Eur J Nutr. 2021;60(1):345–356. doi:10.1007/s00394-020-02250-z.
   PubMed Web of Science ®Google Scholar
• Molina PE, Nelson S. Binge drinking’s effects on the body. Alcohol Res. 2018;39:99–109.
   PubMed Web of Science ®Google Scholar
• Seong H, Choi BK, Han YH, Kim JH, Gim JA, Lim S, Noh JY, Cheong HJ, Kim WJ, Song JY, et al. Gut microbiota as a potential key to modulating humoral immunogenicity of new platform COVID-19 vaccines. Sig Transduct Target Ther. 2023;8(1):178. doi:10.1038/s41392-023-01445-0.
   PubMed Web of Science ®Google Scholar
• Looi MK. How are COVID-19 symptoms changing? BMJ. 2023;380:3. doi:10.1136/bmj.p3.
   PubMedGoogle Scholar
• Bolte LA, Vich Vila A, Imhann F, Collij V, Gacesa R, Peters V, Wijmenga C, Kurilshikov A, Campmans-Kuijpers MJE, Fu J, et al. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome. Gut. 2021;70(7):1287. doi:10.1136/gutjnl-2020-322670.
   PubMed Web of Science ®Google Scholar
• Ren Z, Wang H, Cui G, Lu H, Wang L, Luo H, Chen X, Ren H, Sun R, Liu W, et al. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut. 2021;70(7):1253. doi:10.1136/gutjnl-2020-323826.
   PubMed Web of Science ®Google Scholar
• Cervino ACL, Fabre R, Plassais J, Gbikpi-Benissan G, Petat E, Le Quellenec E, Neuberger-Castillo L, Laurent JM, Iordache L, Bouchahda M, et al. Results from EDIFICE: A French pilot study on COVID-19 and the gut microbiome in a hospital environment. 2022. doi:10.1101/2022.02.06.22269945.
   Google Scholar
• Gutiérrez-Castrellón P, Gandara-Martí T, Abreu AT, Nieto-Rufino CD, López-Orduña E, Jiménez-Escobar I, Jiménez-Gutiérrez C, López-Velazquez G, Espadaler-Mazo J. Probiotic improves symptomatic and viral clearance in covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut Microbes. 2022;14(1):2018899. doi:10.1080/19490976.2021.2018899.
   PubMed Web of Science ®Google Scholar
• Marshall JC, Murthy S, Diaz J, Adhikari NK, Angus DC, Arabi YM, Baillie K, Bauer M, Berry S, Blackwood B, et al. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):e192–e197. doi:10.1016/S1473-3099(20)30483-7.
   PubMed Web of Science ®Google Scholar
• Xu R, Lu R, Zhang T, Wu Q, Cai W, Han X, Wan Z, Jin X, Zhang Z, Zhang C, et al. Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults. Commun Biol. 2021;4(1):240. doi:10.1038/s42003-021-01796-w.
   PubMed Web of Science ®Google Scholar
• Krueger F. Trim Galore. A wrapper tool around cutadapt and FastQC to consistently apply quality and adapter trimming to FastQ files. 2015. https://github.com/FelixKrueger/TrimGalore.
   Google Scholar
• Wood DE, Lu J, Langmead B. Improved metagenomic analysis with kraken 2. Genome Biol. 2019;20(1):257. doi:10.1186/s13059-019-1891-0.
   PubMed Web of Science ®Google Scholar
• Lee M. kraken2_human_and_phiX_db. 2020. doi:10.6084/m9.figshare.12525242.v1.
   Google Scholar
• Dacey DP, Chain FJJ. Concatenation of paired-end reads improves taxonomic classification of amplicons for profiling microbial communities. BMC Bioinform. 2021;22(1):493. doi:10.1186/s12859-021-04410-2.
   PubMed Web of Science ®Google Scholar
• Oksanen J, Blanchet FG, Friendly M, Kindt R, Legendre P, McGlinn D, O’Hara RB, Simpson GL, Solymos P, Stevens MH. Package ‘vegan’. 2013. https://github.com/vegandevs/vegan.
   Google Scholar
• Li J, George Markowitz RH, Brooks AW, Mallott EK, Leigh BA, Olszewski T, Zare H, Bagheri M, Smith HM, Friese KA, et al. Individuality and ethnicity eclipse a short-term dietary intervention in shaping microbiomes and viromes. PLoS Biol. 2022;20(8):e3001758. doi:10.1371/journal.pbio.3001758.
   PubMed Web of Science ®Google Scholar
• Breiman L. Random forests. Mach Learn. 2001;45(1):5–32. doi:10.1023/A:1010933404324.
   Web of Science ®Google Scholar